Tamara Taggart, PhD, MPH
Assistant Professor Adjunct of Public Health (Social & Behavioral Sciences)DownloadHi-Res Photo
Cards
Contact Info
About
Copy Link
Titles
Assistant Professor Adjunct of Public Health (Social & Behavioral Sciences)
Biography
Dr. Taggart conducts socioepidemiologic studies to examine the contextual (e.g., neighborhoods and social networks) and cultural (e.g., religiosity, racial identity, and masculinity) determinants of health, and then uses CBPR methods to develop and implement interventions to reduce HIV risk and substance use among racial/ethnic minority and socioeconomically disadvantaged adolescents and emerging adults. Her current work focuses on two areas: (1) Applying a community engaged framework to examine systems level factors associated with PrEP uptake among adolescents; and (2) Utilizing activity space assessments and biopsychosocial models of stress to examine the mechanisms connecting discriminatory neighborhood environments and HIV-related behaviors. Dr. Taggart is an Assistant Professor at George Washington University Milken Institute School of Public Health.
Last Updated on April 07, 2025.
Departments & Organizations
- Yale School of Public Health
- Yale-UPR Integrated HIV Basic and Clinical Sciences Initiative
Education & Training
- PhD
- University of North Carolina at Chapel Hill (2016)
- MPH
- Columbia University (2010)
- AB
- Dartmouth College (2003)
Research
Copy Link
Overview
Public Health Interests
Community Health; HIV/AIDS; Mental Health; Substance Use, Addiction; Health Equity, Disparities, Social Determinants and Justice
ORCID
0000-0001-9240-1212
Research at a Glance
Yale Co-Authors
Frequent collaborators of Tamara Taggart's published research.
Yusuf Ransome, MPH, DrPH
Lydia Aoun-Barakat, MD
Michael Virata, MD, FACP, FIDSA
Sheela Shenoi, MD, MPH, FIDSA
Publications
2025
Measuring the spatial scale of structural racism and discrimination: Consequences for estimated life expectancy
Hipp J, Wang Y, O'Shea N, Faris R, Espelage D, Valido A, Taggart T. Measuring the spatial scale of structural racism and discrimination: Consequences for estimated life expectancy. Social Science & Medicine 2025, 389: 118811. PMID: 41313904, DOI: 10.1016/j.socscimed.2025.118811.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsStructural racism measuresStructural racismRacism measuresNeighborhood blightMeasures of structural racismLife expectancyMeso-levelLow average life expectancyAverage life expectancyBlack-white inequalityResidential segregationPersistent social disparitiesBlack neighborhoodsBlack/White inequalityHousing vacanciesEviction ratesRacial inequalityRacismLiquor storesSocial disparitiesMultilevel linear modelsMacro levelHealth disparitiesNeighborhoodMultilevel interventionsIncreasing equity to mental health treatment by adapting churches as alternative facilities: a location-allocation analysis
Luan H, Song I, Taggart T, Arnold K, Rice B, Ransome Y. Increasing equity to mental health treatment by adapting churches as alternative facilities: a location-allocation analysis. Health & Place 2025, 96: 103580. PMID: 41252805, DOI: 10.1016/j.healthplace.2025.103580.Peer-Reviewed Original ResearchBeyond Neighbors: Social Capital and Self-Empowerment Among Older Adults Diagnosed with HIV Late
Chantre C, Vu T, Lee M, Wang M, Girma M, Dunham K, Lin-Schweitzer A, Aoun-Barakat L, Shenoi S, Virata M, Taggart T, Ransome Y. Beyond Neighbors: Social Capital and Self-Empowerment Among Older Adults Diagnosed with HIV Late. AIDS And Behavior 2025, 1-12. PMID: 41175146, DOI: 10.1007/s10461-025-04946-x.Peer-Reviewed Original ResearchConceptsParticipants' mean ageOlder peopleQuality of lifeSocial connectednessSelf-empowermentNeighborhood social capitalHIV clinical outcomesChronic disease treatmentHIV stigmaHIV careHIV preventionOlder adultsHIV clinicThematic analysisMedication ratesChronic diseasesStructural interventionsSocial capitalGrounded TheoryAfrican AmericansHIVNew HavenMean ageCareThemesA comparison of HIV pre-exposure prophylaxis accessibility by public transit- and drive-time in Dallas-Fort Worth, Texas, 2024
Luan H, Ransome Y, Taggart T, Chow J, Mancuso N, Grant M, Huang P, Sullivan P. A comparison of HIV pre-exposure prophylaxis accessibility by public transit- and drive-time in Dallas-Fort Worth, Texas, 2024. Health & Place 2025, 96: 103550. PMID: 40986968, DOI: 10.1016/j.healthplace.2025.103550.Peer-Reviewed Original ResearchCitationsConceptsChallenges to Adolescent Pre-exposure Prophylaxis (PrEP) Uptake: an Exploration of Black and Latino American Parents’ Beliefs, Attitudes, and Receptivity to PrEP
Albritton T, Coulibaly K, Taggart T, Bartholomew Z, Oridota O, Springer E, Munoz-Laboy M, Pina P. Challenges to Adolescent Pre-exposure Prophylaxis (PrEP) Uptake: an Exploration of Black and Latino American Parents’ Beliefs, Attitudes, and Receptivity to PrEP. Journal Of Racial And Ethnic Health Disparities 2025, 1-12. PMID: 40779140, DOI: 10.1007/s40615-025-02567-7.Peer-Reviewed Original ResearchAltmetricConceptsPrEP uptakeMedical mistrustLack of PrEP awarenessHIV prevention initiativesBackgroundPre-exposure prophylaxisPre-exposure prophylaxisTeen Health ClinicsPrEP awarenessHealth practicesHealth clinicsLatino adolescentsFocus groupsImpact of family factorsPrevention initiativesEmergent themesLatino communitiesPrEPNew York CityFinancial burdenFamily factorsMinoritized communitiesParental beliefsYork CityParental consentAdolescents“Am I Truly Invisible?”: A Qualitative Study on Black Women's Experiences of and Coping With Intersectional Invisibility in Uterine Fibroid Treatment
Malekzadeh A, Zota A, Lyons M, Taggart T. “Am I Truly Invisible?”: A Qualitative Study on Black Women's Experiences of and Coping With Intersectional Invisibility in Uterine Fibroid Treatment. Women's Health Issues 2025, 35: 342-349. PMID: 40628590, PMCID: PMC12243959, DOI: 10.1016/j.whi.2025.05.005.Peer-Reviewed Original ResearchCitationsConceptsHealth care settingsCare settingsIntersectional invisibilityBlack women's experiencesBlack womenWomen's experiencesThematic analytic approachSocial-structural inequitiesHealth inequalitiesHealth outcomesSocial supportSuperwoman SchemaBlack women’s voicesGendered RacismHealthWomen's voicesObservational researchParticipantsRacismInvisibilitySexismWomenProjection strengthFibroid treatmentInequalityLeveraging U = U in Interventions for Black Women Living With HIV: A Scoping Review and Call To Action
Jones M, Sawyer S, Bowman I, Habib M, Wassertzug D, Taggart T. Leveraging U = U in Interventions for Black Women Living With HIV: A Scoping Review and Call To Action. AIDS And Behavior 2025, 29: 2077-2087. PMID: 40029580, DOI: 10.1007/s10461-025-04670-6.Peer-Reviewed Original ResearchCitationsAltmetricParadox of Progress: NIH-Funded Research on Sexual and Gender Minority Populations, 2012-2022.
Friedman M, Taggart T, Coulter R. Paradox of Progress: NIH-Funded Research on Sexual and Gender Minority Populations, 2012-2022. American Journal Of Public Health 2025, 115: 255-258. PMID: 39938041, PMCID: PMC11845834, DOI: 10.2105/ajph.2024.307986.Peer-Reviewed Original ResearchCitationsP-1415. Social Determinants of Health and Side Effects Significantly Predict Pre-Exposure Prophylaxis (PrEP) Preferences for Every 2 Month Long-Acting Injectable vs. Daily Oral PrEP among Cisgender Women in the United States and the Dominican Republic
Kerrigan D, Scott R, O’Rourke A, Galai N, Karver T, Davis W, Metzner A, Oglesby A, Moriarty P, Taggart T, Barrington C, Gomez H, Perez M, Donastorg Y. P-1415. Social Determinants of Health and Side Effects Significantly Predict Pre-Exposure Prophylaxis (PrEP) Preferences for Every 2 Month Long-Acting Injectable vs. Daily Oral PrEP among Cisgender Women in the United States and the Dominican Republic. Open Forum Infectious Diseases 2025, 12: ofae631.1590. PMCID: PMC11777370, DOI: 10.1093/ofid/ofae631.1590.Peer-Reviewed Original ResearchConceptsPre-exposure prophylaxisLong-actingFemale sex workersSocial determinantsCisgender womenSocial determinants of healthHIV diagnosis ratesDaily oral PrEPDeterminants of healthBlack cisgender womenLow pre-exposure prophylaxisCross-sectional surveyOral PrEPUnited StatesHIV disparitiesWhite cisgender womenHIV inequitiesSide effectsIncreased oddsDiagnosis rateHIVPrEP preferencesDominican RepublicPrEPSex workersP-500. Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic
Metzner A, Oglesby A, O’Rourke A, Galai N, Karver T, Davis W, Scott R, Moriarty P, Taggart T, Barrington C, Gomez H, Perez M, Donastorg Y, Kerrigan D. P-500. Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic. Open Forum Infectious Diseases 2025, 12: ofae631.699. PMCID: PMC11779361, DOI: 10.1093/ofid/ofae631.699.Peer-Reviewed Original ResearchConceptsHIV pre-exposure prophylaxisFemale sex workersOral PrEPPre-exposure prophylaxisLAI-PrEPDaily oral PrEPNumbers of sex partnersReproductive health clinicsSexual health clinicsHealth clinicsCisgender womenAcquired HIVHIV acquisitionLong-actingDaily pillInjectable PrEPPrEP clinicPrimary care clinicsPrEP useLatina ethnicityCondom useHIV knowledgeSex partnersPrEP awarenessHIV
Get In Touch
Copy Link